🔎 Trials Near Me

Utama › Obesiti › Texas › Austin

Kajian klinikal Obesiti di Austin, TX

20 kajian untuk Obesiti sedang mencari peserta di lokasi dalam dan sekitar Austin (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Mengambil pesertaFasa 2
  • Elligo Clinical Research Center /ID# 282166, Austin
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07752979

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Mengambil pesertaFasa 3
  • Texas Diabetes & Endocrinology, Austin
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07668414

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Mengambil pesertaFasa 3
  • Dell Children's Medical Center - PIN, Austin
Umur 6 hingga 17 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Mengambil pesertaFasa 3
  • IMA Clinical Research Austin, Austin
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Mengambil pesertaFasa 3
  • FutureSearch Trials of Neurology, Austin
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Mengambil pesertaFasa 3
  • Austin Heart, Austin
  • Velocity Clinical Research - Austin, Austin
Umur 45 hingga 99 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07037433

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Mengambil pesertaFasa 2
  • IMA Clinical Research Austin, Austin
Umur 18 hingga 75 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07589608

Semaglutide for Post-Smoking Cessation Weight Management

Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
  • The University of Texas at Austin, Austin
Umur 18 hingga 75 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Mengambil pesertaFasa 3
  • AURORA-1 Clinical Site, Austin
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Mengambil pesertaFasa 3
  • AURORA-2 Clinical Site, Austin
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Mengambil pesertaFasa 3
  • Austin Heart, Austin
Umur 18 hingga 99 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07037459

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
  • ACCOMPLISH-2 Research Site, Austin
Umur 18 hingga 79 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Mengambil pesertaFasa 2
  • IMA Clinical Research Austin, Austin
Umur 18 hingga 75 · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Mengambil pesertaFasa 3
  • Elligo Clinical Research Center, Austin
Umur 18 hingga 99 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Mengambil pesertaFasa 3
  • Elligo Clinical Research Center, Austin
Umur 18 hingga 99 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07684144

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Mengambil pesertaFasa 3
  • Austin Heart, Austin
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Mengambil pesertaFasa 3
  • ACCOMPLISH-1 Research Site, Austin
  • ACCOMPLISH-1 Research Site, Austin
Umur 18 hingga 79 · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT07654361

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Mengambil pesertaFasa 1
  • Elligo Clin Res Centre, Austin
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Jun 2026 · NCT07607587

A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets

Mengambil pesertaFasa 1
  • Corxel Investigational Site, Austin
Umur 18 hingga 55 · Wanita · Dikemas kini 17 Jun 2026 · NCT07652047

Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)

Mengambil pesertaSukarelawan sihat dialu-alukan
  • Dell Pediatric Research Center, Austin
  • University of Texas at Austin, Austin
Umur 30 hingga 60 · Wanita · Dikemas kini 9 Jun 2026 · NCT07480109

Kajian Obesiti di bandar lain

Kajian lain di Austin

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.